Pesquisa | Portal de Pesquisa da BVS

1.

Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens.

Crawford, E David; Schellhammer, Paul F; McLeod, David G; Moul, Judd W; Higano, Celestia S; Shore, Neal; Denis, Louis; Iversen, Peter; Eisenberger, Mario A; Labrie, Fernand.

J Urol ; 200(5): 956-966, 2018 11.

Artigo em Inglês | MEDLINE | ID: mdl-29730201

2.

Intermittent versus continuous androgen deprivation in prostate cancer.

Hussain, Maha; Tangen, Catherine M; Berry, Donna L; Higano, Celestia S; Crawford, E David; Liu, Glenn; Wilding, George; Prescott, Stephen; Kanaga Sundaram, Subramanian; Small, Eric Jay; Dawson, Nancy Ann; Donnelly, Bryan J; Venner, Peter M; Vaishampayan, Ulka N; Schellhammer, Paul F; Quinn, David I; Raghavan, Derek; Ely, Benjamin; Moinpour, Carol M; Vogelzang, Nicholas J; Thompson, Ian M.

N Engl J Med ; 368(14): 1314-25, 2013 Apr 04.

Artigo em Inglês | MEDLINE | ID: mdl-23550669

3.

Intermittent androgen suppression for rising PSA level after radiotherapy.

Crook, Juanita M; O'Callaghan, Christopher J; Duncan, Graeme; Dearnaley, David P; Higano, Celestia S; Horwitz, Eric M; Frymire, Eliot; Malone, Shawn; Chin, Joseph; Nabid, Abdenour; Warde, Padraig; Corbett, Thomas; Angyalfi, Steve; Goldenberg, S Larry; Gospodarowicz, Mary K; Saad, Fred; Logue, John P; Hall, Emma; Schellhammer, Paul F; Ding, Keyue; Klotz, Laurence.

N Engl J Med ; 367(10): 895-903, 2012 Sep 06.

Artigo em Inglês | MEDLINE | ID: mdl-22931259

4.

Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

Kantoff, Philip W; Higano, Celestia S; Shore, Neal D; Berger, E Roy; Small, Eric J; Penson, David F; Redfern, Charles H; Ferrari, Anna C; Dreicer, Robert; Sims, Robert B; Xu, Yi; Frohlich, Mark W; Schellhammer, Paul F.

N Engl J Med ; 363(5): 411-22, 2010 Jul 29.

Artigo em Inglês | MEDLINE | ID: mdl-20818862

5.

Oestrogen redux: will transdermal delivery rebalance the risk-benefit equation?

Schellhammer, Paul F.

BJU Int ; 119(5): 653-654, 2017 05.

Artigo em Inglês | MEDLINE | ID: mdl-28393497

6.

Gonadal steroids and body composition, strength, and sexual function in men.

Schellhammer, Paul F.

N Engl J Med ; 369(25): 2456, 2013 12 19.

Artigo em Inglês | MEDLINE | ID: mdl-24350957

7.

Re: Should the Urologist Treat Castration Resistant Prostate Cancer? Yes/No.

Schellhammer, Paul F.

J Urol ; 195(3): 803; discussion 803-4, 2016 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-26638024

8.

Legends in Urology.

Schellhammer, Paul F.

Can J Urol ; 23(3): 8261-4, 2016 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-27347617

9.

Treatment options for localized prostate cancer.

Mohan, Ravinder; Schellhammer, Paul F.

Am Fam Physician ; 84(4): 413-20, 2011 Aug 15.

Artigo em Inglês | MEDLINE | ID: mdl-21842788

10.

A history of the Society of Urologic Oncology.

Lange, Paul H; Cookson, Michael S; Schellhammer, Paul F; Droller, Michael J.

Urol Oncol ; 39(9): 514-520, 2021 09.

Artigo em Inglês | MEDLINE | ID: mdl-33454198

11.

Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer.

Malcolm, John B; Fabrizio, Michael D; Barone, Bethany B; Given, Robert W; Lance, Raymond S; Lynch, Donald F; Davis, John W; Shaves, Mark E; Schellhammer, Paul F.

J Urol ; 183(5): 1822-8, 2010 May.

Artigo em Inglês | MEDLINE | ID: mdl-20303100

12.

Open Label Phase II Study of Enzalutamide With Concurrent Administration of Radium 223 Dichloride in Patients With Castration-Resistant Prostate Cancer.

Shore, Neal D; Schellhammer, Paul F; Tutrone, Ronald F; Mariados, Neil F; Harrelson, Stacey S.

Clin Genitourin Cancer ; 18(5): 416-422, 2020 10.

Artigo em Inglês | MEDLINE | ID: mdl-32475774

13.

Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry.

Sartor, Oliver; Armstrong, Andrew J; Ahaghotu, Chiledum; McLeod, David G; Cooperberg, Matthew R; Penson, David F; Kantoff, Philip W; Vogelzang, Nicholas J; Hussain, Arif; Pieczonka, Christopher M; Shore, Neal D; Quinn, David I; Small, Eric J; Heath, Elisabeth I; Tutrone, Ronald F; Schellhammer, Paul F; Harmon, Matthew; Chang, Nancy N; Sheikh, Nadeem A; Brown, Bruce; Freedland, Stephen J; Higano, Celestia S.

Prostate Cancer Prostatic Dis ; 23(3): 517-526, 2020 09.

Artigo em Inglês | MEDLINE | ID: mdl-32111923

14.

Re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3-7.

Wassersug, Richard J; Schellhammer, Paul F; Wibowo, Erik.

Eur Urol ; 85(6): e173-e174, 2024 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-38538424

15.

Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.

Hubosky, Scott G; Fabrizio, Michael D; Schellhammer, Paul F; Barone, Bethany B; Tepera, Christopher M; Given, Robert W.

J Endourol ; 21(12): 1521-31, 2007 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-18186694

16.

Editorial comment.

Schellhammer, Paul F.

J Urol ; 185(3): 854; author reply 854, 2011 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-21239016

17.

Overexpression of alpha-defensin is associated with bladder cancer invasiveness.

Holterman, Daniel A; Diaz, Jose I; Blackmore, Peter F; Davis, John W; Schellhammer, Paul F; Corica, Alberto; Semmes, Oliver J; Vlahou, Antonia.

Urol Oncol ; 24(2): 97-108, 2006.

Artigo em Inglês | MEDLINE | ID: mdl-16520271

18.

Prospective longitudinal comparative study of early health-related quality-of-life outcomes in patients undergoing surgical treatment for localized prostate cancer: a short-term evaluation of five approaches from a single institution.

Ball, Adam J; Gambill, Bethany; Fabrizio, Michael D; Davis, John W; Given, Robert W; Lynch, Donald F; Shaves, Mark; Schellhammer, Paul F.

J Endourol ; 20(10): 723-31, 2006 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-17094746

19.

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

Adam, Bao-Ling; Qu, Yinsheng; Davis, John W; Ward, Michael D; Clements, Mary Ann; Cazares, Lisa H; Semmes, O John; Schellhammer, Paul F; Yasui, Yutaka; Feng, Ziding; Wright, George L.

Cancer Res ; 62(13): 3609-14, 2002 Jul 01.

Artigo em Inglês | MEDLINE | ID: mdl-12097261

20.

A Urologist's Personal View of Prostate Cancer.

Schellhammer, Paul F.

Turk J Urol ; 42(3): 121-6, 2016 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-27635283

Portal de Pesquisa da BVS

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens.

Intermittent versus continuous androgen deprivation in prostate cancer.

Intermittent androgen suppression for rising PSA level after radiotherapy.

Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

Oestrogen redux: will transdermal delivery rebalance the risk-benefit equation?

Gonadal steroids and body composition, strength, and sexual function in men.

Re: Should the Urologist Treat Castration Resistant Prostate Cancer? Yes/No.

Legends in Urology.

Treatment options for localized prostate cancer.

A history of the Society of Urologic Oncology.

Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer.

Open Label Phase II Study of Enzalutamide With Concurrent Administration of Radium 223 Dichloride in Patients With Castration-Resistant Prostate Cancer.

Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry.

Re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3-7.

Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.

Editorial comment.

Overexpression of alpha-defensin is associated with bladder cancer invasiveness.

Prospective longitudinal comparative study of early health-related quality-of-life outcomes in patients undergoing surgical treatment for localized prostate cancer: a short-term evaluation of five approaches from a single institution.

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

A Urologist's Personal View of Prostate Cancer.